A selection of actionable insight, commentary and analysis on the major trends shaping the structured products markets.
21h
The bank is accelerating its presence in equity derivatives, structured products and actively managed certificates, leveraging quantitative investment solutions (QISS) to provide scalable, regulated access for retail and institutional clients across Asia, Europe, the Middle East and the Americas.
21h
In this week’s wrap, we look at a selection of structured products with strike dates between 8-14 March 2026.
22h
We look at currencies across products issued in Asia in 2025 based on SRP data.
22h
In a conversation with SRP, Super Global’s Daniel Knoblach explains how technology, operational integration and regulatory robustness are shaping the next stage of AMC growth.
12 Mar 2026
With 84% market share in fixed-leverage certificates and 3,000 turbo products on offer, Société Générale continues to lead SeDeX through innovation, education and deep market expertise.
12 Mar 2026
Morgan Stanley issued its first ever public offers in the region while UBS also continued its presence having debuted in Q2.
12 Mar 2026
The long-time RBC derivatives structurer takes the helm of equities exotics and hybrids structuring for the Americas as demand for bespoke derivatives strategies grows.
12 Mar 2026
Structured Uridashi delivered a lagging year (again), and now Japanese investors eye retail Japan Government Bonds and the credit market.
11 Mar 2026
The Dublin-headquartered firm is ramping up issuance while integrating sustainability preferences across advisory and discretionary portfolios.
11 Mar 2026
The German fintech has a dedicated business line to scale actively managed products (AMP) through index-based structures, automation and tokenisation.
11 Mar 2026
The collaboration integrates agentic AI, knowledge graphs and index calculation infrastructure to speed up the creation of thematic strategies.
11 Mar 2026
Embedded options in structured products carry nuanced interest rate exposure. In this analysis, we explore how Rho affects valuation and why the so-called “risk-free” rate is never truly risk-free.